Home › Research › Health systems and care delivery
The “Rising Tide” of dementia in Canada
Feng Chang, Tejal Amar Patel, Mary E. Schulz. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2015-06-17
Topic: Risk, prevention and care in population studies
Plain-language summary
The prevalence of dementia was estimated at 44.4 million people worldwide in 2013, and in the absence of any significant new scientific discovery, prevalence rates are estimated to increase to 75.6 million in 2030 and 135.5 million in 2050.1 Alzheimer’s disease is the most common irreversible form of dementia. Pharmacists play a vital role in the health and overall well-being of all Canadians.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Chang, F., Patel, T. A., & Schulz, M. E. (2015). The “Rising Tide” of dementia in Canada. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. https://doi.org/10.1177/1715163515588107
Vancouver
Chang F, Patel TA, Schulz ME. The “Rising Tide” of dementia in Canada. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 2015. doi:10.1177/1715163515588107. PMID: 26862334.
BibTeX
@article{chang2015-26862334,
author = {Chang, Feng and Patel, Tejal Amar and Schulz, Mary E.},
title = {{The “Rising Tide” of dementia in Canada}},
journal = {Canadian Pharmacists Journal / Revue des Pharmaciens du Canada},
year = {2015},
doi = {10.1177/1715163515588107},
pmid = {26862334},
url = {https://doi.org/10.1177/1715163515588107}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The prevalence of dementia was estimated at 44.4 million people worldwide in 2013, and in the absence of any significant new scientific discovery, prevalence rates are estimated to increase to 75.6 million in 2030 and 135.5 million in 2050.1 Alzheimer’s disease is the most common irreversible form of dementia.
- Pharmacists play a vital role in the health and overall well-being of all Canadians.
Why it matters
This article reports projected increases in dementia prevalence worldwide and notes that Alzheimer's disease is the most common irreversible form of dementia. It provides no findings on treating, curing, or preventing Alzheimer's disease.
Study details
- Evidence strengthLow
How this study scored 34/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Canadian Pharmacists Journal / Revue des Pharmaciens du Canada) |
| Journal's citation record | 0 / 4 | Canadian Pharmacists Journal / Revue des Pharmaciens du Canada: journal h-index 41 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2015 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 30 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.3 citations a year over 13 year(s) since 2015 |
| Impact for its field and year | 2 / 6 | Cited 1.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 6 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Mary E. Schulz: h-index 6 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Waterloo: institution h-index 782 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 26862334) |
| Free to read | 2 / 2 | Free to read |
| Total | 34 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Health systems and care delivery from nearby years
Also tagged “prevalence”
1,223 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,223 tagged studies.